AbstrAct: Saint Louis encephalitis virus, a member of the flaviviridae subgroup, is a culex mosquitoborne pathogen. Despite severe epidemic outbreaks on several occasions, not much progress has been made with regard to an epitopebased vaccine designed for Saint Louis encephalitis virus. The envelope proteins were collected from a protein database and analyzed with an in silico tool to identify the most immunogenic protein. The protein was then verified through several parameters to predict the Tcell and Bcell epitopes. Both Tcell and Bcell immunity were assessed to determine that the protein can induce humoral as well as cellmediated immunity. The peptide sequence from 330-336 amino acids and the sequence REYCYEATL from the position 57 were found as the most potential Bcell and Tcell epitopes, respectively. Furthermore, as an RNA virus, one important thing was to establish the epitope as a conserved one; this was also done by in silico tools, showing 63.51% conservancy. The epitope was further tested for binding against the HLA molecule by computational docking techniques to verify the binding cleft epitope interaction. However, this is a preliminary study of designing an epitopebased peptide vaccine against Saint Louis encephalitis virus; the results awaits validation by in vitro and in vivo experiments.
Introduction
Saint Louis encephalitis virus (SLEV) is related to Japanese encephalitis virus and belongs to the family Flaviviridae (Group B arborviruses), genus Flavivirus. It mainly affects the United States and, in occasional cases, Mexico and Canada. 1, 2 The principle reservoirs of SLEV include domes tic fowl and wild birds. The virus is transmitted to humans from wild birds via mosquito vectors (Culex tarsalis, C pipiens, and C quinquefasciatus). 3 SLEV is a single stranded, envelo ped, positivesense ribonucleic acid (RNA) virus and has a relatively conserved nucleotide sequence. 4 In all, 4437 cases of SLEV infection were reported across the United States since 1964 with an average of 128 cases per year. The fatality rate caused by the disease ranges from 5% to 15%. SLEV infec tion fatality rates are generally lower in children than adults, but the cases in which children were infected, the encephalitis rate was higher. The severity of the disease increases with age, and the disease is most prevalent in people over the age of 60. Hypertension and vascular diseases may act as risk factors for infection. Encephalitis is recognized as the emerging disease in the United States. 5 The risk of exposure to SLEV infec tion in urban areas is increasing, as the deterioration of inner cities can make new habitats for mosquitoes. There is no spe cific treatment for SLEV infection; care is based on only a few symptoms. No vaccine against SLEV or specific antivi ral treatment for clinical SLEV infections is available. 6 For all these reasons, it is important to develop a new vaccine for Saint Louis encephalitis virus, and despite no technical dif ficulties having been reported, new vaccine development has not yet been achieved. These viruses contain 3 structural pro teins: nucleocapsid, premembrane (prM), and envelope (E). The envelope protein is particularly important for vaccine development as it mediates viral entry by interacting with host cell surface receptors and is also the primary target of adaptive immune response. 7 It would be of great value if the protec tive epitopes associated with this envelope protein were well known, and, if they could be produced synthetically, it would be possible to offer consistent cost and quality advantages over the current treatment. 8 Synthetic peptides are being tested as potential vaccines in a wide range of infectious diseases. The use of synthetic peptides or epitopes could offer an important contribution to protection against SLEV. 9 Current immunoinformatics tools are able to predict human Bcell and Tcell linear epitopes with high accuracy. These tools are playing a vital role in under standing the molecular basis of immunity and, notably in the development of epitope basedpeptide vaccines, immunother apy against cancer and autoimmune diseases. [10] [11] [12] [13] This approach could save substantial time and cost, especially for researchers in countries with limited resources. The concept of computer aided vaccine design has proven to be essential for combating diseases such as multiple sclerosis, 14 malaria, 15 and tumors. 16 For epitopebased vaccine design, identification of HLA ligands and Tcell epitopes are the most crucial steps. 17 Tcell epitope prediction tools assist in identifying allelespecific binding peptides, thus reducing the number of potential pep tides to be considered as vaccine candidates. These tools help researchers to identify regions with high concentrations of Tcell epitopes or immunological "hot spots" and thus open a new window for rationalitybased vaccine design. A number of methods have been developed to facilitate the identification of proteasomal peptide cleavage sites, major histocompatibility complex (MHC) binding peptides, and transporters associated with antigen presentation (TAP) molecules. [18] [19] [20] [21] These meth ods use a variety of statistical and machine learning approaches to assist computational prescreening of immunogenic epitopes for vaccine design. Similar immunoinformatics approaches are being developed for other organisms and will constitute the base for the design of a new generation epitope vaccines. Our present study concerns the computational prediction of immu nogenic epitopes of the Saint Louis encephalitis virus and design of a synthetic peptide vaccine candidate. We hypoth esize that this envelope protein comprises a linear epitope with an efficacy close to 100%.
Materials and Methods
Protein sequence retrieval. The outer membrane protein (envelope proteins) sequences of Saint Louis encephalitis were retrieved from UniProtKB (www.uniprot.org/) in FASTA format. The sequence was analyzed with a view to recognizing the immunologically relevant regions, which is done by study ing antigenicity, solvent accessible regions, and MHC class I and II binding sites.
Identification of antigenic proteins. The envelope proteins were then submitted in the VaxiJen 22 with default parameters to isolate the antigenic proteins. All the antigenic proteins with their respective score were then filtered in Excel. A single antigenic protein with highest antigenicity scores was selected for further evaluation. secondary structure prediction. ExPASy's secondary structure prediction server (http://web.expasy.org/prot param/) and selfoptimized prediction method with alignment (SOPMA) 23 were used to get an idea about the secondary structure of the chosen protein. Several parameters given by the ProtParam tool, for example, molecular weight, theoreti cal pI, amino acid composition, atomic composition, extinc tion coefficient, estimated halflife, instability index, aliphatic index, and grand average of hydropathicity (GRAVY) were executed for this purpose. Secondary structure prediction of a protein aims to predict solvent accessibility, transmembrane helices, globular regions, and coiledcoil regions. The objec tives of this step were to determine the protein's stability and function.
Identification of t-cell epitope. Linear peptides as Tcell epitopes were selected by NetCTL server. 24 The whole protein sequence was submitted in the server, which was based on neu ral network architecture, and all the super types were chosen. The parameter was set at 50 to have sensitivity and specificity of 0.89 and 0.94, respectively. This allowed the opportunity to focus on more epitopes critically. A combined algorithm of MHC1 binding, transporter of antigenic peptide (TAP) transport efficiency and proteosomal cleavage efficiency were involved to predict overall scores. Based on this overall score, 5 best epitopes were selected for further experimentation.
MHC1 binding prediction, 25 a different prediction method, was available in the Immune Epitope Database (IEDB). The Stabilized Matrix Base Method (SMM) was used to cal culate IC50 values of peptide binding to MHC1 mole cules. For all the alleles, peptide length was set to 9 amino acids prior to the prediction. The alleles having binding affinity IC50 less than 200 nm were chosen for further consideration.
For the selected epitopes, a webbased tool, proteasomal cleavage/TAP transport/MHC class 1 combined predictor, 26 was also implemented to predict proteasomal cleavage score, TAP score, processing score, and MHC1 binding score using SMM for each peptide.
Prediction of epitope conservancy. Epitope conservancy for individual peptides was predicted using the epitope tool from the IEDB analysis resource. 27 docking simulation study. The predicted epitope was further tested by in silico docking simulation to find out whether or not this peptide will bind to the HLA molecules when it will be applied in vivo. To accomplish the simulation, 3 LKN, a crystal structure of the HLAB*3501 molecule, was retrieved from the Protein Data Bank (PDB). 28 Prior to dock ing simulation, the influenza NP418 epitope, which was com plexed in the binding groove of HLAB*3501, was removed by using AutoDockTools. Docking simulation for the pre dicted epitope with prepared HLAB*3501 was done by using Autodock Vina. 29 Then again influenza NP418 epitope was docked with HLAB*3501 mentioned earlier, to compare the binding energy of the epitope.
Identification of b-cell epitope. The Bcell epitope is the portion of the antigen which interacts with Blymphocytes. As a result, the Blymphocyte is differentiated into antibody secreting plasma cell and memory cells. In other terms, the objective of the Bcell epitope is to ultimately stimulate the B cell to synthesize the antibody specific for it (primary humoral response) or to convert the naïve B cell into a memory B cell and make it ready to produce specific antibody in later encounters. 30 A Bcell epitope is characterized by being hydrophilic, accessible, and in a flexible region of an immunogen. 31 Thus, Kolaskar and Tongaonkar antigenicty scale, 32 Emini surface accessibility prediction, 33 Parker hydrophilicity prediction, 34 Karplus and Schulz flexibilty prediction 35 and Bepipred linear epitope prediction analysis were done computationally from the IEDB analysis resource. 36 In several experimental studies, it was found that the antigenic parts of a protein belong to the beta turn regions. 37 Therefore, the Chou and Fashman beta turn prediction tool 38 was used. The results from all these sites were crossreferenced, and apparently common findings were taken as the Bcell epitopes.
results

Protein retrieval and antigenic protein prediction.
A total of 75 envelope proteins were retrieved from UniprotKB in FASTA format and then subjected to VaxiJen to predict the most immunogenic protein. UniprotKB id: B6C6 W4 was predicted as the most immunogenic protein with a total score of 0.6591, which is a glycoprotein among all envelope proteins. Finding of this prediction coincides with a previ ous finding where envelope glycoprotein was presented as an immunogenic protein. 39 secondary structure analysis. The most immunogenic protein was analyzed for its secondary structural characteris tics, and the properties shown in Table 1 and Figure 1 were found.The protein was characterized as a neutral charged pro tein, as the number of positively charged residues (Arg+Lys) and negatively charged residues (Asp+Glu) were the same (ie, 46). The total amino acid distribution showed that alanine, glycine, leucine, lysine, serine, threonine, and valine constitute 57% of the protein. Though all these amino acids except lysine have acidic pI (from 6.0 for Alanine to 5.6 for valine), the net pI of the protein tended to be slightly basic (pI 7.24), maybe due to the relatively higher abundance of lysine (5.2%) with a very high basic pI (9.74). The basic character of the protein ascribes the protein to be a nonallergen. 40 The secondary character shows an important feature of the protein as an antigenic one. In several experiments, it was shown that the antigenic part of the protein is more likely to belong to the beta sheet region. 41 Regarding this fact, it was found that this protein contained the highest percentage (11%) of the threonine residue, which prefers to lie in the beta sheet, indirectly indi cating the probability of the protein's antigenicity. Moreover, the grand average of the hydrophobicity rule (GRAVY) of the protein linear sequence was predicted to be negative (−0.079) showing the protein as hydrophilic in nature and predicting most of the residues to be present in the surface. In addition, the aliphatic and the instability index of the protein described it as an aliphatic and stable protein, respectively. t-cell epitope prediction. The NetCTL prediction tool predicted epitopes from the given protein sequence accord ing to all supertypes. But only 5 most potential epitopes were chosen on the basis of high combinatorial scores. The SMMbased IEDB MHC1 binding prediction tool retrieved 406 possible MHC1 allele interactions with the 5 Tcell epitopes that were selected before. The MHC1 alleles for which the epitopes showed higher affinity (IC50 , 200) were selected for further analysis (Table 2 ). Binding affinity of the epitopes with the MHC1 alleles had an inverse relation ship with the IC50 values.
The proteasome complex includes enzymes that cleave the peptide bonds, converting the proteins into peptide. The pep tide molecules from proteasome cleavage associate with class1 MHC molecules and the peptideMHC molecule then trans port to the cell membrane where they are presented to T helper cell. Before that, TAP (transporter of antigenic peptides) trans fers it to the endoplasmic reticulum. In this case, the total score was predicted, and the higher the score meant the higher the efficiency of all these processes. The predicted total score of all these processes are summarized in All the measurements were spaced at the scale of 1 angstrom. These coordinates were chosen and calculated to aid the epitope sequence to bind to the binding groove of the receptor. The binding energy of predicted epitope with HLAB*3501 recep tor was found to be 7.6 kcal/mol (Fig. 2, C and D) . This bind ing energy was compared with the binding energy of influenza NP418 epitope to HLA B*3501 and found to be the same as the predicted epitope (7.6 kcal/mol, Figure 2, A and B) . Similar binding energy of both the simulations indicates the satisfactory accuracy of the predicted epitope.
b-cell epitope identification. Characteristic features of the Bcell epitope include hydrophilicity, surface accessibility, and betaturn prediction. Thus, several prediction methods were used to determine the epitope considering all these criteria. Kolaskar and Tongaonkar antigenicity prediction method functions on the basis of physiochemical properties of amino acids and abundances in experimentally known epitopes.
The antigenic propensity for the protein was 1.00; all the values greater than 1.00 are potential antigenic determi nants. Thirteen epitopes were found to satisfy the threshold value set prior to the analysis, and they have the potential to evoke the Bcell response. The peptide from PCRVPIS VTAN from 335 to 345 was found to have the highest antigenic propensity score. The results are summarized in Table 3A and Figure 3 .
Hydrophilic regions are likely to be exposed to the outer surface and most likely to evoke Bcell antigenecity. For this pur pose, the protein was subjected to Emini surface accesibilty pre diction (Table 3B ) and Parker hydrophilicity prediction (Fig. 4) . From these 2 prediction methods, the regions around 70 to 80 (more specifically 77-87 in the Emini surface accessibility pre diction method), 140 to 156 (more specifically 146-156, surface accessibility prediction method), 240 to 250 (more specifically 242-250 in the Emini surface accessibility prediction method), and 320 to 330 (more specifically 327-332 in the Emini surface accessibility prediction method) were found as hydrophilic. And thus, these regions can be said to be antigenic.
It was found experimentally that the segment of protein that interacted with the antibody was flexible. For this reason, the flexibility of the segment was also counted in the search of antigenicty. In the Karplus and Schulz flexibility prediction method, the region of 330 to 340 was found to be the most flexible (Fig. 5) .
Admitting the effect of the beta sheet region in antige nicity, Chou and Fashman betaturn prediction was done. In this result, approximately100 to 105 and approximately 330 to 340 regions were shown to have the highest betaturn regions (Fig. 6) .
The singlescale amino acid propensity profile cannot always reliably predict the antigenic epitopes, and even the best antigenic prediction method could yield a slightly bet ter score than the receiver operating characteristics (ROC) plot. 42 Because of this, a machine learning process, Bepipred, was done to predict the epitopes with increased success (Table 3C) .
By crossreferencing all the data, we hypothesized that the peptide sequence from 330-336 amino acids are capable of inducing the desired immune response as Bcell epitopes. to determine these epitopes. All the vaccines at present are mostly based on Bcell immunity, whereas, in this case, a vac cine based on Tcell epitope was inspired by the fact that the host can mediate a strong immune response by CD8+ T cell to infected cell. 44 In this approach, an attempt was made to illuminate a potential but rather overlooked aspect of vac cine development. 45 Tcell based vaccine development is very promising in the sense that due to antigenic drift, the foreign particles can easily escape the antibody memory response. On the contrary, a Tcell immune response tends to be a lasting one. Along with the Tcell epitope, attention was given also to the Bcell epitope, which can induce primary and secondary humoral immunity. 46 This study evolved around the cornerstone of 4 criteria of a good peptide epitope: good conservancy, Tcell and Bcell processivity, interaction with MHC1 allele with good affin ity, and population coverage.
The predicted epitope fulfilled all the criteria, while more explanation of some results is given here including the fact that as a RNA virus, Saint Louis encephalaitis has a higher ten dency towards mutation resulting from the lack of proofreading activity of RNA polymerase. 47 So, while considering the seg ment to induce immunity in the human body against this virus, it is of utmost importance to choose a portion with relative conservancy. The most preferable way to do that in a dry lab will be to consider a portion present in all the strains of the virus. By securing a presence in a specific protein in all strains, it actually secures a place in evolution. But unfortunately, due to resource scarcity, among the 17 strains till identified, 1 the data base includes only the protein sequence of strain MS1-7. Thus in this approach this problem was tried to solve from a different angle. The 5 most potential Tcell epitopes chosen by the server NetCTL were again subjected to the epitope conservancy tool.
One epitope, REYCYEATL, showed a conservancy of 63.51%, while the other 4 epitopes showed conservancy of only 40.54%. It was assumed that the REYCYEATL epitope could be used as a universal epitope rather than other 4, as it showed higher conservancy than all other potential epitopes.
In the fourth criteria, to make sure the interacting MHC alleles has good population coverage overall, 12 allele super types were set prior to the epitope prediction, where super types A*0101, A*0201, A*0301, A*2402, B*0702, and B*4403 showed a population coverage of 99%, including North American, where the disease is most prevalent. 48 Most importantly, REYCYEATL also showed interac tion with HLAA2, which is more common in North America than the other parts of the world. 49 Other four Epitopes did not show interaction with the HLAA2.
Some investigations were done using multiple com putational tools, such as in the case of Bcell epitope identification, which was done using the parameters of hydrophilicity, flexibility, and betaturn. This emphasizes the fact that although computational algorithms are avail able, it is still important to check all the criteria in vitro to assess the immunogenicity and identify the epitopes of a protein.
The results are based on a careful sequence analysis and deposited data on various immune databases. The results suggest that the epitopes found here are good candidates for establishing a peptide vaccine that can trigger an efficacious immune response in vivo.
conclusion and Future Perspective
To prove the effectiveness of mounting an immune response, both in vivo and in vitro studies are required along with this in silico study. To determine the binding affinity of the whole peptide, the binding chip assay for the HLA and peptide would also be useful.
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